Cytochrome P450-redox partner fusion enzymes

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 3, 2007, Pages 345-359

  Munro, Andrew W ^a   Girvan, Hazel M ^a   McLean, Kirsty J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Catalytic cycle; Chimera; Cytochrome P450; Domain; Electron transfer; Enzyme mechanism; Ferredoxin; Flavodoxin; Flavoprotein; Fusion protein; Heme binding; Linker; Peroxidase; Phthalate dioxygenase reductase; Redox partner

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 BM3; CYTOCHROME P450 REDUCTASE; FATTY ACID; HYBRID PROTEIN; OXIDOREDUCTASE; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

BACILLUS MEGATERIUM; CATALYSIS; ELECTRON; ELECTRON TRANSPORT; ENZYME ANALYSIS; EUKARYOTE; EVOLUTION; GENOME ANALYSIS; KNOWLEDGE; MOLECULE; OXYGENATION; PRIORITY JOURNAL; PROKARYOTE; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BINDING SITES; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; ELECTRON TRANSPORT; EVOLUTION, MOLECULAR; FERREDOXINS; HUMANS; MIXED FUNCTION OXYGENASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NADP; NADPH-FERRIHEMOPROTEIN REDUCTASE; OXIDATION-REDUCTION; OXYGEN; RECOMBINANT FUSION PROTEINS;

BACILLUS MEGATERIUM; EUKARYOTA; PROKARYOTA;

EID: 33846356640     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.08.018     Document Type: Review

References (120)

1. Guengerich F.P. Cytochrome P450: what have we learned and what are the future issues?. Drug Metab. Rev. 36 (2004) 159-197
2. Rodriguez-Antona C., and Ingelman-Sundberg M. Cytochrome P450 pharmacogenetics and cancer. Oncogene 25 (2006) 1671-1679
3. Pikuleva I., and Waterman M.R. Cytochromes P450 in synthesis of steroid hormones, bile acids, vitamin D3 and cholesterol. Mol. Aspects Med. 20 (1999) 33-42
4. Xue Y., and Sherman D.H. Biosynthesis and combinatorial biosynthesis of pikromycin-related macrolides in Streptomyces venezuelae. Metab. Eng. 3 (2001) 15-26
5. Sligar S.G., Makris T.M., and Denisov I.G. Thirty years of microbial P450 monooxygenase research: peroxo-heme intermediates-The central bus station in heme oxygenase catalysis. Biochem. Biophys. Res. Commun. 338 (2005) 346-354
6. Urlacher V.B., Lutz-Wahl S., and Schmid R.D. Microbial P450 enzymes in biotechnology. Appl. Microbiol. Biotechnol. 64 (2004) 317-325
7. Kubo T., Peters M.W., Meinhold P., Arnold F.H., and Bernhardt R. Enantioselective epoxidation of terminal alkenes to (R)- and (S)-epoxides by engineered cytochromes P450 BM-3. Chemistry 12 (2006) 1216-1220
8. cam. J. Am. Chem. Soc. 125 (2003) 705-714
9. cam monooxygenase. J. Mol. Biol. 336 (2004) 889-902
10. Murataliev M.B., Feyereisen R., and Walker F.A. Electron transfer by diflavin reductases. Biochim. Biophys. Acta 1698 (2004) 1-26
11. Makris T.M., von Koenig K., Schlichtling I., and Sligar S.G. The status of high-valent metal oxo complexes in the P450 cytochromes. J. Inorg. Biochem. 100 (2006) 507-518
12. Daiber A., Shoun H., and Ullrich V. Nitric oxide reductase (P450nor) from Fusarium oxysporum. J. Inorg. Biochem. 99 (2005) 185-193
13. Lee D.S., Yamada A., Sugimoto H., Matsunaga I., Ogura H., Ichihara K., Adachi S., Park S.Y., and Shiro Y. Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis. Crystallographic, spectroscopic, and mutational studies. J. Biol. Chem. 278 (2003) 9761-9767
14. Lawson R.J., Leys D., Sutcliffe M.J., Kemp C.A., Cheesman M.R., Smith S.J., Clarkson J., Smith W.E., Haq I., Perkins J.B., and Munro A.W. Thermodynamic and biophysical characterization of cytochrome P450 BioI from Bacillus subtilis. Biochemistry 43 (2004) 12410-12426
15. Puchkaev A.V., Wakagi T., and Ortiz de Montellano P.R. CYP119 plus a Sulfolobus tokodaii strain 7 ferredoxin and 2-oxoacid:ferredoxin oxidoreductase constitute a high-temperature cytochrome P450 catalytic system. J. Am. Chem. Soc. 124 (2002) 12682-12683
16. Narhi L.O., and Fulco A.J. Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J. Biol. Chem. 261 (1986) 7160-7169
17. Muller J.J., Lapko A., Bourenkov G., Ruckpaul K., and Heinemann U. Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J. Biol. Chem. 276 (2001) 2786-2789
18. McLean K.J., Sabri M., Marshall K.R., Lawson R.J., Lewis D.G., Clift D., Balding P.R., Dunford A.J., Warman A.J., McVey J.P., Quinn A.M., Sutcliffe M.J., Scrutton N.S., and Munro A.W. Biodiversity of cytochrome P450 redox systems. Biochem. Soc. Trans. 33 (2005) 796-801
19. Loida P.J., and Sligar S.G. Molecular recognition in cytochrome P-450: mechanism for the control of uncoupling reactions. Biochemistry 32 (1993) 11530-11538
20. Noble M.A., Miles C.S., Chapman S.K., Lysek D.A., MacKay A.C., Reid G.A., Hanzlik R.P., and Munro A.W. Roles of key active-site residues in flavocytochrome P450 BM3. Biochem. J. 339 (1999) 371-379
21. Powell P.K., Wolf I., Jin R., and Lasker J.M. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J. Pharmacol. Exp. Ther. 285 (1998) 1327-1336
22. Munro A.W., Daff S., Coggins J.R., Lindsay J.G., and Chapman S.K. Probing electron transfer in flavocytochrome P450 BM3 and its component domains. Eur. J. Biochem. 239 (1996) 403-409
23. Munro A.W., Leys D., McLean K.J., Marshall K.R., Ost T.W., Daff S., Miles C.S., Chapman S.K., Lysek D.A., Moser C.C., Page C.C., and Dutton P.L. P450 BM3: the very model of a modern flavocytochrome. Trends Biochem. Sci. 27 (2002) 250-257
24. cam and reduced putidaredoxin. J. Biol. Chem. 263 (1988) 791-798
25. Perera R., Sono M., Raner G.M., and Dawson J.H. Subzero-temperature stabilization and spectroscopic characterization of homogeneous oxyferrous complexes of the cytochrome P450 BM3 (CYP102) oxygenase domain and holoenzyme. Biochem. Biophys. Res. Commun. 338 (2005) 365-371
26. Sono M., Perera R., Jin S., Makris T.M., Sligar S.G., Bryson T.A., and Dawson J.H. The influence of substrate on the spectral properties of oxyferrous wild-type and T252A cytochrome P450-CAM. Arch. Biochem. Biophys. 436 (2005) 40-49
27. F.P. Guengerich, Human cytochrome P450 enzymes, in: P.R. Ortiz de Montellano (Ed.), Cytochrome P450, Structure, Mechanism and Biochemistry (3rd Edition), Kluwer Academic/Plenum Publishers, New York, 2005, pp. 377-530.
28. T.M. Makris, I. Denisov, I. Schlichtling, S.G, Sligar, Activation of molecular oxygen by cytochrome P450, in: P.R. Ortiz de Montellano (Ed.), Cytochrome P450, Structure, Mechanism and Biochemistry (3rd Edition), Kluwer Academic/Plenum Publishers, New York, 2005, pp. 149-182.
29. cam can be engineered to oxidize ethane to ethanol. Angew. Chem. Int. Ed. 44 (2005) 4029-4032
30. Imai M., Shimada H., Watanabe Y., Matsushima-Hibiya Y., Makino R., Koga H., Horiuchi T., and Ishimura Y. Uncoupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine or valine: possible role of the hydroxyl amino acid in oxygen activation. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 7823-7827
31. cam to increase the stereospecificity and coupling of aliphatic hydroxylation. Protein Eng. 6 (1993) 207-212
32. Atkins W.M., and Sligar S.G. Metabolic switching in cytochrome P-450cam: deuterium isotope effects on regiospecificity and the monooxygenase/oxidase ratio. J. Am. Chem. Soc. 109 (1987) 3754-3760
33. Shertzer H.G., Clay C.D., Genter M.B., Chames M.C., Schneider S.N., Oakley G.G., Nebert D.W., and Dalton T.P. Uncoupling-mediated generation of reactive oxygen by halogenate aromatic hydrocarbons in mouse liver microsomes. Free Radic. Biol. Med. 36 (2004) 618-631
34. cam hydroxylase operon. Biol. Pharm. Bull. 22 (1999) 1110-1112
35. Wang J., and Ortiz de Montellano P.R. The binding sites on human heme oxygenase-1 for cytochrome P450 reductase and biliverdin reductase. J. Biol. Chem. 278 (2003) 20069-20076
36. 5 and cytochrome P450 reductase. J. Biol. Chem. 273 (1998) 17036-17049
37. Nishino H., and Ishibashi T. Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol D7-reductase system. Arch. Biochem. Biophys. 374 (2000) 293-298
38. Fulco A.J. P450BM-3 and other inducible bacterial P450 cytochromes: biochemistry and regulation. Annu. Rev. Pharmacol. Toxicol. 31 (1991) 177-203
39. Shaw G.C., and Fulco A.J. Barbiturate-mediated regulation of expression of the cytochrome P450BM-3 gene of Bacillus megaterium by Bm3R1 protein. J. Biol. Chem. 267 (1992) 5515-5526
40. He J.S., Liang Q., and Fulco A.J. The molecular cloning and characterization of BM1P1 and BM1P2 proteins, putative positive transcription factors involved in barbiturate-mediated induction of the genes encoding cytochrome P450BM-1 of Bacillus megaterium. J. Biol. Chem. 270 (1995) 18615-18625
41. Miles J.S., Munro A.W., Rospendowski B.N., Smith W.E., McKnight J., and Thomson A.J. Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization. Biochem. J. 288 (1992) 503-509
42. Gustafsson M.C., Palmer C.N., Wolf C.R., and von Wachenfeldt C. Fatty-acid-displaced transcriptional repressor, a conserved regulator of cytochrome P450 102 transcription in Bacillus species. Arch. Microbiol. 176 (2001) 459-464
43. Nakayame N., Takemae A., and Shoun H. Cytochrome P450foxy, a catalytically self-sufficient fatty acid hydroxylase of the fungus Fusarium oxysporum. J. Biochem. 119 (1996) 435-440
44. Narhi L.O., and Fulco A.J. Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. J. Biol. Chem. 262 (1987) 6683-6690
45. Porter T.D. An unusual yet strongly conserved flavoprotein reductase in bacteria and mammals. Trends Biochem. Sci. 16 (1991) 154-158
46. Ruettinger R.T., and Fulco A.J. Epoxidation of unsaturated fatty acids by a soluble cytochrome P-450-dependent system from Bacillus megaterium. J. Biol. Chem. 256 (1981) 5728-5734
47. Graham-Lorence S., Truan G., Peterson J.A., Falck J.R., Wei S., Helvig C., and Capdevila J.H. An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase. J. Biol. Chem. 272 (1997) 1127-1135
48. Oliver C.F., Modi S., Sutcliffe M.J., Primrose W.U., Lian L.Y., and Roberts G.C. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation. Biochemistry 36 (1997) 1567-1572
49. Munro A.W., Lindsay J.G., Coggins J.R., Kelly S.M., and Price N.C. Structural and enzymological analysis of the interaction of isolated domains of cytochrome P-450 BM3. FEBS Lett. 343 (1994) 70-74
50. Neeli R., Girvan H.M., Lawrence A., Warren M.J., Leys D., Scrutton N.S., and Munro A.W. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase. FEBS Lett. 579 (2005) 5582-5588
51. Black S.D., and Martin S.T. Evidence for conformational dynamics and molecular aggregation in cytochrome P450 102 (BM-3). Biochemistry 33 (1994) 12056-12062
52. Daff S.N., Chapman S.K., Turner K.L., Holt R.A., Govindaraj S., Poulos T.L., and Munro A.W. Redox control of the catalytic cycle of flavocytochrome P-450 BM3. Biochemistry 36 (1997) 13816-13823
53. Govindaraj S., and Poulos T.L. The domain architecture of cytochrome P450BM-3. J. Biol. Chem. 272 (1997) 7915-7921
54. Sevrioukova I.F., Li H., Zhang H., Peterson J.A., and Poulos T.L. Structure of a cytochrome P450-redox partner electron-transfer complex. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1863-1888
55. Li H., and Poulos T.L. The structure of the cytochrome P450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat. Struct. Biol. 4 (1997) 140-146
56. Ravichandran K.G., Boddupalli S.S., Hasemann C.A., Peterson J.A., and Deisenhofer J. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science 261 (1993) 731-736
57. Haines D.C., Tomchick D.R., Machius M., and Peterson J.A. Pivotal role of water in the mechanism of P450BM-3. Biochemistry 40 (2001) 13456-13465
58. Girvan H.M., Marshall K.R., Lawson R.J., Leys D., Joyce M.G., Clarkson J., Smith W.E., Cheesman M.R., and Munro A.W. Flavocytochrome P450 BM3 mutant A264E undergoes substrate-dependent formation of a novel heme iron ligand set. J. Biol. Chem. 279 (2004) 23274-23286
59. Joyce M.G., Girvan H.M., Munro A.W., and Leys D. A single mutation in cytochrome P450 BM3 induces the conformational rearrangement seen upon substrate binding in the wild-type enzyme. J. Biol. Chem. 279 (2004) 23287-23293
60. Sem D.S., and Kasper C.B. Interaction with arginine 597 of NADPH-cytochrome P-450 oxidoreductase is a primary source of the uniform binding energy used to discriminate between NADPH and NADH. Biochemistry 32 (1993) 11548-11558
61. Neeli R., Roitel O., Scrutton N.S., and Munro A.W. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes. J. Biol. Chem. 280 (2005) 17634-17644
62. Dohr O., Paine M.J., Friedberg T., Roberts G.C., and Wolf C.R. Engineering of a functional human NADH-dependent cytochrome P450 system. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 81-86
63. Gutierrez A., Dohr O., Paine M.J., Wolf C.R., Scrutton N.S., and Roberts G.C. Trp-676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: properties of the soluble W676H and W676A mutant reductases. Biochemistry 39 (2000) 15990-15999
64. Ost T.W., Miles C.S., Murdoch J., Cheung Y., Reid G.A., Chapman S.K., and Munro A.W. Rational re-design of the substrate binding site of flavocytochrome P450 BM3. FEBS Lett. 486 (2000) 173-177
65. Peters M.W., Glieder M.A., and Arnold F.H. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. J. Am. Chem. Soc. 125 (2003) 13442-13450
66. Landwehr M., Hochrein L., Otey C.R., Kasrayan A., Backvall J.E., and Arnold F.H. Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone batalyzed by engineered cytochrome P450 BM-3. J. Am. Chem. Soc. 128 (2006) 6058-6059
67. Ost T.W., Munro A.W., Mowat C.G., Taylor P.R., Pesseguiero A., Fulco A.J., Cho A.K., Cheesman M.R., Walkinshaw M.D., and Chapman S.K. Structural and spectroscopic analysis of the F393H mutant of flavocytochrome P450 BM3. Biochemistry 40 (2001) 13430-13438
68. Ost T.W., Miles C.S., Munro A.W., Murdoch J., Reid G.A., and Chapman S.K. Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3. Biochemistry 40 (2001) 13421-13429
69. Klein M.L., and Fulco A.J. Critical residues involved in FMN binding and catalytic activity in cytochrome P450BM-3. J. Biol. Chem. 268 (1993) 7553-7561
70. Gutierrez A., Lian L.Y., Wolf C.R., Scrutton N.S., and Roberts G.C. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains. Biochemistry 40 (2001) 1964-1975
71. Nakayama N., and Shoun H. Subterminal hydroxylation of fatty acids by a cytochrome P-450-dependent enzyme system from a fungus, Fusarium oxysporum. J. Biochem. 97 (1985) 755-763
72. Kitazume T., Takaya N., Nakayama N., and Shoun H. Fusarium oxysporum fatty-acid subterminal hydroxylase (CYP505) is a membrane-bound eukaryotic counterpart of Bacillus megaterium cytochrome P450BM3. J. Biol. Chem. 275 (2000) 39734-39740
73. Murataliev M.B., and Feyereisen R. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain. Biochemistry 35 (1996) 15029-15037
74. Craig D.H., Chapman S.K., and Daff S. Calmodulin activates electron transfer through neuronal nitric-oxide synthase reductase domain by releasing an NADPH-dependent conformational lock. J. Biol. Chem. 277 (2002) 33987-33994
75. Seo J.A., Proctor R.H., and Plattner R.D. Characterization of four clustered and coregulated genes associated with fumonisin biosynthesis in Fusarium verticillioides. Fungal Genet. Biol. 34 (2001) 155-165
76. Gustafsson M.C., Roitel O., Marshall K.R., Noble M.A., Chapman S.K., Pessegueiro A., Fulco A.J., Cheesman M.R., von Wachenfeldt C., and Munro A.W. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium. Biochemistry 43 (2004) 5474-5487
77. Munro A.W., Noble M.A., Ost T.W., Green A.J., McLean K.J., Robledo L., Miles C.S., Murdoch J., and Chapman S.K. Flavocytochrome P450 BM3 substrate selectivity and electron transfer in a model cytochrome P450. Sub-cell. Biochem. 35 (2000) 297-315
78. Munro A.W., Quaroni L., Chumanov G.D., Turner K.L., Chapman S.K., Hanzlik R.P., and Munro A.W. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3. Biochemistry 37 (1998) 15799-15807
79. Wolthers K.R., and Scrutton N.S. Electron transfer in human methionine synthase reductase studied by stopped-flow spectrophotometry. Biochemistry 43 (2004) 490-500
80. Paine M.J., Garner A.P., Powell D., Sibbald J., Sales M., Pratt N., Smith T., Tew D.G., and Wolf C.R. Cloning and characterization of a novel human dual flavin reductase. J. Biol. Chem. 275 (2000) 1471-1478
81. Dunford A.J., Marshall K.R., Munro A.W., and Scrutton N.S. Thermodynamic and kinetic analysis of the isolated FAD domain of rat neuronal nitric oxide synthase altered in the region of the FAD shielding residue Phe 1395. Eur. J. Biochem. 271 (2004) 2548-2560
82. Govidaraj S., and Poulos T.L. Probing the structure of the linker connecting the reductase and heme domains of cytochrome P450BM-3 using site-directed mutagenesis. Protein Sci. 5 (1996) 1389-1393
83. Stuehr D.J., Santolini J., Wang Z.Q., Wei C.C., and Adak S. Update on mechanism and catalytic regulation in the NO synthases. J. Biol. Chem. 279 (2004) 36167-36170
84. Panda K., Ghosh S., and Stuehr D.J. Calmodulin activates intersubunit electron transfer in the neuronal nitric oxide synthase dimer. J. Biol. Chem. 276 (2001) 23349-23356
85. Stuehr D.J., Wei C.C., Wang Z., and Hille R. Exploring the redox reactions between heme and tetrahydrobiopterin in the nitric oxide synthases. Dalton Trans. 2005 (2005) 3427-3435
86. De Mot R., and Parret A.H.A. A novel class of self-sufficient cytochrome P450 mono-oxygenases in prokaryotes. Trends Microbiol. 10 (2002) 502-508
87. Gibson D.T., and Parales R.E. Aromatic hydrocarbon dioxygenases in environmental biotechnology. Curr. Opin. Biotechnol. 11 (2000) 236-243
88. Gassner G.T., Ludwig M.L., Gatti D.L., Correll C.C., and Ballou D.P. Structure and mechanism of the iron-sulfur flavoprotein phthalate dioxygenase reductase. FASEB J. 9 (1995) 1411-1418
89. Tarasev M., and Ballou D.P. Chemistry of the catalytic conversion of phthalate into its cis-dihydrodiol during the reaction of oxygen with the reduced form of phthalate dioxygenase. Biochemistry 44 (2005) 6197-6207
90. Tarasev M., Rhames F., and Ballou D.P. Rates of the phthalate dioxygenase reaction with oxygen are dramatically increased by interactions with phthalate and phthalate oxygenase reductase. Biochemistry 43 (2004) 12799-12808
91. Correll C.C., Batie C.J., Ballou D.P., and Ludwig M.L. Phthalate dioxygenase reductase: a modular structure for electron transfer from pyridine nucleotide to [2Fe-2S]. Science 258 (1992) 1604-1610
92. Roberts G.A., Celik A., Hunter D.J., Ost T.W., White J.H., Chapman S.K., Turner N.J., and Flitsch S.L. A self-sufficient cytochrome P450 with a primary structural organization that includes a flavin domain and a [2Fe-2S] center. J. Biol. Chem. 278 (2003) 48914-48920
93. Nagy I., Compernolle F., Ghys K., Vanderleyden J., and De Mot R. A single cytochrome P-450 system in involved in degradation of the herbicides EPTC (S-ethyl dipropylthiocarbamate) and atrazine by Rhodococcus sp. Strain N186/21. Appl. Environ. Microbiol. 61 (1995) 2056-2060
94. Mayhew S.G., and Tollin G. General properties of flavodoxins. In: Muller F. (Ed). Chemistry and Biochemistry of Flavodoxins vol. 3 (1992), CRC Press, Boca Raton, FL 389-426
95. Fujii K., Galivan J.H., and Hennekens F.M. Activation of methionine synthase: a further characterization of the flavoprotein system. Arch. Biochem. Biophys. 78 (1977) 662-670
96. Nieva-Gomez D., Roberts G.P., Klevickis S., and Brill W.J. Electron transport to nitrogenase in Klebsiella pneumoniae. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 2255-2258
97. Blaschkowski H.P., Neuer G., Ludwig-Festl M., and Knappe J. Routes of flavodoxin and ferredoxin reduction in Escherichia coli. CoA-acylating pyruvate: flavodoxin and NADPH flavodoxin oxidoreductases participating in the activation of pyruvate-formation lyase. Eur. J. Biochem. 123 (1982) 563-569
98. Wang M., Roberts D.L., Paschke R., Shea T.M., Masters B.S.S., and Kim J.-J.P. Three dimensional structure of NADPH-cytochrome P450 reductase-prototype for FAD- and FMN-containing enzymes. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9411-9416
99. Hanley S.C., and Daff S. The unusual redox properties of flavocytochrome P450 BM3 flavodoxin domain. Biochem. Biophys. Res. Commun. 325 (2004) 1418-1423
100. Murataliev M.B., and Feyereisen R. Functional interactions in cytochrome P450 BM3: evidence that NADP(H) binding controls redox potentials of the flavin cofactors. Biochemistry 39 (2000) 12699-12707
101. Cryle M.J., and De Voss J.J. Carbon-carbon bond cleavage by cytochrome P450 BioI (CYP107H1). Chem. Commun. 2004 (2004) 86-87
102. Lawson R.J., von Wachenfeldt C., Haq I., Perkins J., and Munro A.W. Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI. Biochemistry 43 (2004) 12390-12409
103. Hawkes D.B., Adams G.W., Burlingame A.L., Ortiz de Montellano P.R., and De Voss J.J. Cytochrome P450cin (CYP176A), isolation, expression, and characterization. J. Biol. Chem. 277 (2002) 27725-27732
104. Rylott E.L., Jackson R.G., Edwards J., Womack G.L., Seth-Smith H.M.B., Rathbone D.A., Strand S.E., and Bruce N.C. An explosive-degrading cytochrome P450 activity and its targeted application for the phytoremediation of RDX. Nat. Biotechnol. 24 (2006) 216-219
105. Jackson C.J., Lamb D.C., Marczylo T.M., Warrilow A.G.S., Manning N.J., Lowe D.J., Kelly D.E., and Kelly S.L. A novel sterol 14α-demethylase/ferredoxin fusion protein (McCYP51FX) from Methylococcus capsulatus represents a new class of the cytochrome P450 superfamily. J. Biol. Chem. 277 (2002) 46959-46965
106. Waterman M.R., and Lepesheva G.I. Sterol 14a-demethylase, an abundant and essential mixed-function oxidase. Biochem. Biophys. Res. Commun. 338 (2005) 418-422
107. Odds F.C., Brown A.J., and Gow N.A. Antifungal agent: mechanisms of action. Trends Microbiol. 11 (2003) 272-279
108. Podust L.M., Poulos T.L., and Waterman M.R. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3068-3073
109. McLean K.J., Marshall K.R., Richmond A., Hunter I.S., Fowler K., Kieser T., Gurcha S.S., Besra G.S., and Munro A.W. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology 148 (2002) 2937-2949
110. Bellamine A., Mangla A.T., Nes W.D., and Waterman M.R. Characterization and catalytic properties of the sterol 14α-demethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8937-8942
111. McLean K.J., Warman A.J., Seward H.E., Marshall K.R., Cheesman M.R., Waterman M.A., and Munro A.W. Characterization of the Mycobacterium tuberculosis ferredoxin (Fdx) and interactions with its cognate redox partner: the sterol demethylase P450 CYP51. Biochemistry 45 (2006) 8427-8443
112. Fisher C.W., Shet M.S., Caudle D.L., Martin-Wixtrom C.A., and Estabrook R.W. High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10817-10821
113. Shet M.S., Fisher C.W., Holmans P.L., and Estabrook R.W. Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11748-11752
114. Fantuzzi A., Meharenna Y.T., Briscoe P.B., Sassone C., Borgia B., and Gilardi G. Improving catalytic properties of P450 BM3 haem domain electrodes by molecular Lego. Chem. Commun. 2006 (2006) 1289-1291
115. cam triple fusion protein. J. Biol. Chem. 271 (1996) 22462-22469
116. cam monooxygenase can be redesigned to catalyze the regioselective aromatic hydroxylation of diphenylmethane. J. Chem. Soc., Chem. Commun. 24 (1994) 2761-2762
117. Sukumaran S., Atkins W.M., and Shanker R. Engineering cytochrome P-450s: chimeric enzymes. Appl. Biochem. Biotechnol. 102-103 (2002) 291-302
118. Nodate M., Kubota M., and Misawa N. Functional expression system for cytochrome P450 genes using the reductase domain of self-sufficient P450RhF from Rhodococcus sp. NCIMB 9784. Appl. Biochem. Biotechnol. 2005 (2005) 1-8
119. Hubbard P.A., Shen A.L., Paschke R., Kasper C.B., and Kim J.J. NADPH-cytochrome P450 oxidoreductase. Structural basis for hydride and electron transfer. J. Biol. Chem. 276 (2001) 29163-29170
120. Roitel O., Scrutton N.S., and Munro A.W. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase. Biochemistry 42 (2003) 10809-10821